198 related articles for article (PubMed ID: 34034728)
1. Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya AI; Pineda C; López I; Millán Y
BMC Vet Res; 2021 May; 17(1):197. PubMed ID: 34034728
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
3. Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry.
Sassi F; Benazzi C; Castellani G; Sarli G
BMC Vet Res; 2010 Jan; 6():5. PubMed ID: 20109214
[TBL] [Abstract][Full Text] [Related]
4. Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification.
Gama A; Alves A; Schmitt F
Virchows Arch; 2008 Aug; 453(2):123-32. PubMed ID: 18677512
[TBL] [Abstract][Full Text] [Related]
5. Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.
Abadie J; Nguyen F; Loussouarn D; Peña L; Gama A; Rieder N; Belousov A; Bemelmans I; Jaillardon L; Ibisch C; Campone M
Breast Cancer Res Treat; 2018 Jan; 167(2):459-468. PubMed ID: 29063312
[TBL] [Abstract][Full Text] [Related]
6. Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.
Kim NH; Lim HY; Im KS; Kim JH; Sur JH
J Comp Pathol; 2013 May; 148(4):298-306. PubMed ID: 23079102
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
Mainenti M; Rasotto R; Carnier P; Zappulli V
Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
Pastor N; Ezquerra LJ; Santella M; Caballé NC; Tarazona R; Durán ME
Vet Comp Oncol; 2020 Dec; 18(4):753-762. PubMed ID: 32336005
[TBL] [Abstract][Full Text] [Related]
10. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinicopathological characteristics and oestrogen receptor gene expression in oestrogen receptor-negative, progesterone receptor-positive canine mammary carcinomas.
Kim NH; Lim HY; Im KS; Shin JI; Kim HW; Sur JH
J Comp Pathol; 2014 Jul; 151(1):42-50. PubMed ID: 24913515
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
13. Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors.
Im KS; Kim IH; Kim NH; Lim HY; Kim JH; Sur JH
Vet J; 2013 Mar; 195(3):366-72. PubMed ID: 22901454
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a new histological and molecular-based classification of canine mammary neoplasia.
Im KS; Kim NH; Lim HY; Kim HW; Shin JI; Sur JH
Vet Pathol; 2014 May; 51(3):549-59. PubMed ID: 24003019
[TBL] [Abstract][Full Text] [Related]
15. Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs.
Watson J; Wang T; Ho KL; Feng Y; Mahawan T; Dobbin KK; Zhao S
Breast Cancer Res; 2023 Oct; 25(1):114. PubMed ID: 37789381
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of FOXP3 expression in canine mammary gland tumours.
Oh SY; Ryu HH; Yoo DY; Hwang IK; Kweon OK; Kim WH
Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
[TBL] [Abstract][Full Text] [Related]
17. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 mRNA and protein expression in canine mammary carcinomas: Correlation with histopathological grade and molecular markers.
Bae MK; Ko YU; Seung BJ; Sur JH; Choe NH
Vet Pathol; 2024 May; 61(3):402-409. PubMed ID: 38281145
[TBL] [Abstract][Full Text] [Related]
19. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
20. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]